US 11319356
Interferon alpha 2B variants
granted A61PA61P35/00A61P39/00
Quick answer
US patent 11319356 (Interferon alpha 2B variants) held by TEVA PHARMACEUTICALS AUSTRALIA PTY LTD expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
- Grant date
- Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P35/00, A61P39/00